REMARK guidelines for tumour biomarker study reporting: a remarkable history
REMARK guidelines for tumour biomarker study reporting: a remarkable history
复制标题
DOI：
10.1038/s41416-022-02046-4
复制
发表时间：
2022-12-07
影响因子：
8.8
通讯作者：
McShane, Lisa M.
中科院分区：
文献类型：
--
作者：
Hayes, Daniel F.;Sauerbrei, Willi;McShane, Lisa M.
2005年，几位肿瘤生物标志物研究专家提出了肿瘤标志物预后研究（REMARK）标准的报告建议。结合随后的生物样本报告以提高研究质量（BRISQ）标准，这些举措为透明地报告研究实施和分析方法提供了一个框架。
In 2005, several experts in tumor biomarker research publishe the REporting recommendations for Tumor MARKer prognostic studies (REMARK) criteria. Coupled with the subsequent Biospecimen Reporting for Improved Study Quality (BRISQ) criteria, these initiatives provide a framework for transparently reporting of the methods of study conduct and analyses.